Find verified Acalabrutinib maleate API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Acalabrutinib maleate for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Acalabrutinib maleate API.
Alternate Names: Calquence maleate, LV51EK7IGP
CAS No: 2242394-65-4
PubChem CID: 126506029
Mol Formula: C30H27N7O6
Mol Weight: 581.6 g/mol
IUPAC Name: 4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide;(Z)-but-2-enedioic acid
API Description: Acalabrutinib Maleate is the maleate form of acalabrutinib, an orally available inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, acalabrutinib inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is overexpressed in B-cell malignancies; it plays an important role in B lymphocyte development, activation, signaling, proliferation and survival.
